Zobrazeno 1 - 10
of 862
pro vyhledávání: '"T A Wadden"'
Publikováno v:
Obesity Science & Practice, Vol 5, Iss 4, Pp 342-353 (2019)
Summary Objective Weight bias internalization (WBI) is associated with poor weight‐related health. The purpose of this study was to identify the prevalence and correlates of WBI in a large sample of adults in a commercial weight management programm
Externí odkaz:
https://doaj.org/article/99b7226283ad40b6a13058d3773d78c0
Autor:
J. Rushing, R. Wing, T. A. Wadden, W. C. Knowler, M. Lawlor, M. Evans, T. Killean, M. Montez, M. A. Espeland, P. Zhang, The Look AHEAD Research Group
Publikováno v:
Obesity Science & Practice, Vol 3, Iss 1, Pp 15-24 (2017)
Summary Objective The Action for Health in Diabetes (Look AHEAD) trial was a randomized controlled clinical trial to compare the effects of 10 years of intensive lifestyle intervention (ILI) with a control condition of diabetes support and education
Externí odkaz:
https://doaj.org/article/e85fe9cf02d54ad782f17d45a950ab32
Autor:
L. Aust
Publikováno v:
Food / Nahrung. 38:104-104
Autor:
A M, Chao, T A, Wadden, R L, Pearl, N, Alamuddin, S M, Leonard, Z M, Bakizada, E, Pinkasavage, K A, Gruber, O A, Walsh, R I, Berkowitz, N, Alfaris, J S, Tronieri
Publikováno v:
Clinical obesity. 8(6)
Antiobesity medication may help people maintain diet-induced reductions in appetite. The present exploratory analysis assessed the effects of lorcaserin on changes at 24 weeks post-randomization in emotion- and stress-related eating, food cravings, a
Publikováno v:
Clinical obesity. 8(2)
Weight discrimination affects a significant proportion of individuals with obesity and contributes to poor mental and physical health. Prior research on weight discrimination has been limited by a lack of racial diversity in samples, and has not cons
Autor:
T A, Wadden, P, Hollander, S, Klein, K, Niswender, V, Woo, P M, Hale, L, Aronne, Sean, Wharton
Publikováno v:
International Journal of Obesity. 37:1443-1451
Liraglutide, a once-daily human glucagon-like peptide-1 analog, induced clinically meaningful weight loss in a phase 2 study in obese individuals without diabetes. The present randomized phase 3 trial assessed the efficacy of liraglutide in maintaini
Autor:
Cool, Daniel1 (AUTHOR) daniel.cool@health.qld.gov.au, Coventon, James1,2 (AUTHOR), Sharma, Abhishek3 (AUTHOR), Bialasiewicz, Alexander (AUTHOR) bialasiewicza@ahlihospital.com
Publikováno v:
Case Reports in Ophthalmological Medicine. 12/10/2024, Vol. 2024, p1-5. 5p.
Autor:
Joyce, Jack B.1 jack.joyce@phc.ox.ac.uk, Newbert, Carolyn2, Guess, Nicola1, Fryer, Kate3, Mitchell, Caroline A.4, Bespala, Liliia1, Morris, Elizabeth1, Aveyard, Paul1, Jebb, Susan A.1, Albury, Charlotte1
Publikováno v:
Health Expectations. Dec2024, Vol. 27 Issue 6, p1-13. 13p.
Autor:
Zhao, Qian1 (AUTHOR), Liu, Dongming2 (AUTHOR), Baranova, Ancha3,4 (AUTHOR), Cao, Hongbao3 (AUTHOR), Zhang, Fuquan1,5 (AUTHOR) zfqeee@126.com
Publikováno v:
CNS Neuroscience & Therapeutics. Nov2024, Vol. 30 Issue 11, p1-10. 10p.
Autor:
Zhang ZQ; Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China., Liao D; Department of Radiology, Guizhou Provincial People's Hospital, Guiyang, China., Guo ZP; Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China., Song SS; Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China., Liu XJ; Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Publikováno v:
Journal of neuroscience research [J Neurosci Res] 2024 Dec; Vol. 102 (12), pp. e70001.